KRAS and non-small cell lung carcinoma: In NSCLC, KRAS mutations are often accompanied by loss of the tumor suppressor STK11, which encodes the LKB1 kinase, leading to the formation of aggressive tumors characterized by perturbed nitrogen handling (9).